Results: 5000
Ibrutinib Is the First Anticancer Agent to Be Negotiated for Medicare Drug Pricing.
- Published in:
- ONS Voice, 2023, p. 1
- By:
- Publication type:
- Article
FDA Approves Melphalan as a Liver-Directed Treatment for Uveal Melanoma.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
FDA Grants Accelerated Approval to Elranatamab-Bcmm for Multiple Myeloma.
- Published in:
- ONS Voice, 2023, p. 2
- Publication type:
- Article
FDA Approves Niraparib and Abiraterone Acetate Plus Prednisone for BRCA-Variant Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- ONS Voice, 2023, p. 1
- Publication type:
- Article
Oncology Drug Reference Sheet: Adagrasib.
- Published in:
- ONS Voice, 2023, p. 2
- By:
- Publication type:
- Article
Oncology Drug Reference Sheet: Teclistamab-Cqyv.
- Published in:
- ONS Voice, 2023, p. 2
- By:
- Publication type:
- Article
U.S. Senators Tina Smith and Jerry Moran Reintroduce Oral Parity for Cancer Drugs Bill.
- Published in:
- ONS Voice, 2023, p. 1
- By:
- Publication type:
- Article
FDA Approves Talazoparib With Enzalutamide for HRR Gene--Variant Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- ONS Voice, 2023, p. 2
- Publication type:
- Article
U.S. Congress Must Empower FDA to Solve Cancer Drug Shortages, Representative Pallone Urges.
- Published in:
- ONS Voice, 2023, p. 2
- By:
- Publication type:
- Article
Oxaliplatin-Loaded Chitosan Nanoparticles Decorated with Cetuximab Single-Chain Variable Fragment for Human Colorectal Cancer Treatment.
- Published in:
- Cell Journal (Yakhteh), 2024, v. 26, n. 9, p. 530, doi. 10.22074/cellj.2024.2033893.1607
- By:
- Publication type:
- Article
Polysaccharide Fraction Isolated from Saccharina japonica Exhibits Anti-Cancer Effects Through Immunostimulating Activities.
- Published in:
- Marine Drugs, 2025, v. 23, n. 1, p. 38, doi. 10.3390/md23010038
- By:
- Publication type:
- Article
Antiviral Activity of the Marine Haptophyta Diacronema lutheri.
- Published in:
- Marine Drugs, 2025, v. 23, n. 1, p. 12, doi. 10.3390/md23010012
- By:
- Publication type:
- Article
Encapsulated LyeTx III Peptide: Cytotoxic Agent Isolated from Lycosa erythrognatha Spider Venom.
- Published in:
- Toxins, 2025, v. 17, n. 1, p. 32, doi. 10.3390/toxins17010032
- By:
- Publication type:
- Article
Integrating Analytical Procedures in Routine Practices of Centralized Antiblastic Compounding Units for Valorization of Residual Compounded Drugs.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 101, doi. 10.3390/pharmaceutics17010101
- By:
- Publication type:
- Article
Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer Mechanisms.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 66, doi. 10.3390/pharmaceutics17010066
- By:
- Publication type:
- Article
Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 57, doi. 10.3390/pharmaceutics17010057
- By:
- Publication type:
- Article
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 46, doi. 10.3390/pharmaceutics17010046
- By:
- Publication type:
- Article
Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 42, doi. 10.3390/pharmaceutics17010042
- By:
- Publication type:
- Article
Ethanolic Extract of Averrhoa carambola Leaf Has an Anticancer Activity on Triple-Negative Breast Cancer Cells: An In Vitro Study.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 1, p. 2, doi. 10.3390/pharmaceutics17010002
- By:
- Publication type:
- Article
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 1, p. 72, doi. 10.3390/ph18010072
- By:
- Publication type:
- Article
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 1, p. 62, doi. 10.3390/ph18010062
- By:
- Publication type:
- Article
Fabrication and In Vivo Evaluation of In Situ pH-Sensitive Hydrogel of Sonidegib–Invasomes via Intratumoral Delivery for Basal Cell Skin Cancer Management.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 1, p. 31, doi. 10.3390/ph18010031
- By:
- Publication type:
- Article
Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 1, p. 110, doi. 10.3390/v17010110
- By:
- Publication type:
- Article
In silico assessment of coriander leaf extract active compound to resensitize oxaliplatin resistance in colorectal cancer mediated by ABCG2 and UPF1 proteins.
- Published in:
- Notulae Scientia Biologicae, 2024, v. 16, n. 4, p. 1, doi. 10.15835/nsb16412125
- By:
- Publication type:
- Article
Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs).
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1463520
- By:
- Publication type:
- Article
Ruthenium-based complexes as anti-tumor agents.
- Published in:
- Journal of Health Sciences, 2024, v. 14, n. 2, p. 70, doi. 10.17532/jhsci.2024.2693
- By:
- Publication type:
- Article
Anticancer activity of new quinolinyl–benzothiazolyl clubbed with amino acids and their in-silico studies.
- Published in:
- Journal of the Iranian Chemical Society, 2025, v. 22, n. 1, p. 219, doi. 10.1007/s13738-024-03144-1
- By:
- Publication type:
- Article
Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways.
- Published in:
- Journal of Pharmacy & Pharmacology, 2025, v. 77, n. 1, p. 1, doi. 10.1093/jpp/rgae132
- By:
- Publication type:
- Article
In silico evaluation, characterization, and in vitro anticancer activity of curcumin–nimbin loaded nanoformulation in HCT-116 cell lines.
- Published in:
- Biotechnologia, 2024, v. 105, n. 4, p. 355, doi. 10.5114/bta.2024.145256
- By:
- Publication type:
- Article
FDA Updates Drug Labeling for Fludarabine Phosphate Under Project Renewal.
- Published in:
- Oncology Practice Management, 2025, v. 15, n. 1, p. 16
- Publication type:
- Article
Eventos adversos notificados ao sistema nacional de notificação (VigiMed) envolvendo medicamentos antineoplásicos no Brasil.
- Published in:
- Saúde e Pesquisa, 2024, v. 17, n. 4, p. 108, doi. 10.17765/2176-9206.2024v17n4.e12816
- By:
- Publication type:
- Article
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review.
- Published in:
- Leukemia & Lymphoma, 2025, v. 66, n. 2, p. 229, doi. 10.1080/10428194.2024.2412289
- By:
- Publication type:
- Article
Transplant oncology and anti-cancer immunosuppressants.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1520083
- By:
- Publication type:
- Article
Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01820-z
- By:
- Publication type:
- Article
Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2024.1466875
- By:
- Publication type:
- Article
Exercise-induced extracellular vesicles in reprogramming energy metabolism in cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1480074
- By:
- Publication type:
- Article
Recent advances in improved efficacies of gold nano-formulations in treatment of skin cancer: a systematic review.
- Published in:
- Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-025-03817-8
- By:
- Publication type:
- Article
PHYTOCCHEMICAL INVESTIGATION AND ANTICANCER ACTIVITY OF DALBERGIA SISSOO ROOTS ON MCF-7 CELL LINE.
- Published in:
- Biochemical & Cellular Archives, 2024, p. 4183, doi. 10.51470/bca.2024.24.1-S.4183
- By:
- Publication type:
- Article
EVALUATION OF ANTICANCER ACTIVITY OF SOME CHEMICAL CONSTITUENT FROM WEDELIA PLANT BY USING IN SILICO APPROACH.
- Published in:
- Biochemical & Cellular Archives, 2024, p. 3507, doi. 10.51470/bca.2024.24.1-S.3507
- By:
- Publication type:
- Article
Status analysis of quality control of administered infusion solution with cytotoxic drugs.
- Published in:
- Oncology Reviews, 2025, p. 1, doi. 10.3389/or.2024.1415677
- By:
- Publication type:
- Article
Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure.
- Published in:
- Archives of Toxicology, 2025, v. 99, n. 1, p. 259, doi. 10.1007/s00204-024-03900-5
- By:
- Publication type:
- Article
Retraction Note: Application of zinc oxide nano-tube as drug-delivery vehicles of anticancer drug.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Capacities of metal-doped nanocages for flutamide and cyclophosphamide delivery as anticancer drug.
- Published in:
- Journal of Molecular Modeling, 2025, v. 31, n. 1, p. 1, doi. 10.1007/s00894-024-06231-5
- By:
- Publication type:
- Article
Intercalation of the anticancer drug lenalidomide into montmorillonite for bioavailability improvement: a computational study.
- Published in:
- Journal of Molecular Modeling, 2025, v. 31, n. 1, p. 1, doi. 10.1007/s00894-024-06210-w
- By:
- Publication type:
- Article
SRT3025-loaded cell membrane hybrid liposomes (3025@ML) enhanced anti-tumor activity of Oxaliplatin via inhibiting pyruvate kinase M2 and fatty acid synthase.
- Published in:
- Lipids in Health & Disease, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12944-025-02431-x
- By:
- Publication type:
- Article
In silico approach for predicting the bioactive compound of Cyperus rotundus to inhibit NF-kB and iNOS signaling pathways.
- Published in:
- Brazilian Journal of Biology, 2024, v. 84, p. 1, doi. 10.1590/1519-6984.278323
- By:
- Publication type:
- Article
Evaluation of the Anti-Cancer Efficacy of Cyclooxygenase Inhibition in Combination with Nutrient Starvation on Pancreatic Ductal Adenocarcinoma In Vitro.
- Published in:
- Turkish Journal of Immunology, 2024, v. 12, n. 3, p. 114, doi. 10.4274/tji.galenos.2025.29290
- By:
- Publication type:
- Article
Non-pharmacological interventions for side effects of antineoplastic chemotherapy prioritized by patients: systematic review.
- Published in:
- Revista Cuidarte, 2024, v. 15, n. 3, p. 1, doi. 10.15649/cuidarte.3612
- By:
- Publication type:
- Article
Lebanese Cannabis sativa L. extract protects from cisplatin-induced nephrotoxicity in mice by inhibiting podocytes apoptosis.
- Published in:
- Journal of Cannabis Research, 2025, v. 7, n. 1, p. 1, doi. 10.1186/s42238-025-00260-4
- By:
- Publication type:
- Article
Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0317111
- By:
- Publication type:
- Article